4//SEC Filing
Quinn Anthony G. 4
Accession 0001209191-22-018942
CIK 0001636282other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 6:32 PM ET
Size
9.8 KB
Accession
0001209191-22-018942
Insider Transaction Report
Form 4
Quinn Anthony
Director
Transactions
- Purchase
Common Stock
2022-03-15$1.86/sh+42,417$78,942→ 473,461 total - Purchase
Common Stock
2022-03-11$2.06/sh+34,777$71,780→ 363,572 total - Purchase
Common Stock
2022-03-14$1.93/sh+67,472$130,221→ 431,044 total
Holdings
- 266,295(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.995 to $2.10 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F2]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.80 to $1.93 per share, inclusive.
- [F3]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.89 to $2.00 per share, inclusive.
- [F4]Includes 57,450 shares of common stock held by the Anthony G. Quinn Irrevocable Trust of 2018 and 208,845 shares of common stock held by the Quinn Family Irrevocable Trust of 2021(together, the "Trusts"). The Reporting Person's spouse is trustee of the Trusts.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001532219
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 6:32 PM ET
- Size
- 9.8 KB